Early onset colorectal cancer – personal experience 2012–2021
Authors:
I. Mikoviny Kajzrlíková 1; P. Vítek 2; P. Klvaňa 1; J. Kuchař 1; J. Platoš 1; J. Chalupa 1
Authors place of work:
Interní oddělení, Beskydské Gastrocentrum, Nemocnice ve Frýdku-Místku, příspěvková organizace
1; Interní oddělení, LF OU a Beskydské Gastrocentrum, Nemocnice ve Frýdku-Místku, příspěvková organizace
2
Published in the journal:
Gastroent Hepatol 2023; 77(3): 221-224
Category:
Gastrointestinal Oncology: Original Article
doi:
https://doi.org/10.48095/ccgh2023221
Summary
Background: Early onset colorectal cancer is defined as cancer diagnosed before the age of 50 years. Its incidence has been increasing worldwide in recent years. The aim of our study was to assess the real-life incidence of early onset colorectal cancer, advanced neoplasias (colorectal cancer and/or advanced adenoma) and all neoplastic lesions in total in a single non-university endoscopic center. Methods: We retrospectively evaluated the incidence of all neoplastic lesions, advanced neoplasias and colorectal cancer in population under 50 years of age compared to population aged 50 years and older. We collected the data from all colonoscopic examinations performed in non-university Hospital Frydek-Mistek from January 2012 to the end of June 2021. Results: During the observed period, 18,257 colonoscopic examinations were performed in total, 14,728 in population aged 50 years and older and 3,529 in population under 50 years of age. In our study, there were 29 patients with early onset colorectal cancer (5.21% of 557 total) and 106 patients with early onset advanced neoplasias (4.47% of 2,371 total). The incidence of colorectal cancer, advanced neoplasias and all neoplasias was higher among men in older study group, but the incidence of early onset colorectal cancer and advanced neoplasias in younger group did not significantly differ between the sexes, only the incidence of all neoplastic lesions was also higher among men. Positive family history of colorectal cancer was not significantly associated with risk of early onset colorectal cancer (p = 0.316) or early onset advanced neoplasia (p = 0.323) in our study. Conclusions: Early onset colorectal cancer represented 5.21% of all colorectal cancers diagnosed during the study period. The incidence of colorectal cancer and advanced neoplasias in population under 50 years of age was 0.82% and 3.00%, compared with 3.59% and 15.38% in older population. In contrast to older population, the incidence of early onset colorectal cancer and advanced neoplasias did not differ between the sexes.
Keywords:
diagnosis – colorectal cancer – mass screening – population groups
Zdroje
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68 (1): 7–30. doi: 10.3322/caac.21442.
2. Epidemiologie zhoubných nádorů v České republice. 2021 [online]. Dostupné z: www.svod.cz.
3. Sinicrope FA. Increasing Incidence of Early-Onset Colorectal Cancer. N Engl J Med 2022; 386 (16): 1547–1558. doi: 10.1056/NEJMra2200869.
4. Mauri G, Sartore-Bianchi A, Russo AG et al. Early-onset colorectal cancer in young individuals. Mol Oncol 2019; 13 (2): 109–131. doi: 10.1002/1878-0261.12417.
5. Bailey CE, Hu CY, You YN et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg 2015; 150 (1): 17–22. doi: 10.1001/jamasurg.2014.1756.
6. Collaborative R, Zaborowski AM, Abdile A et al. Characteristics of Early-Onset vs Late-Onset Colorectal Cancer: A Review. JAMA Surg 2021; 156 (9): 865–874. doi: 10.1001/jamasurg. 2021.2380.
7. Wolf AM, Fontham ET, Church TR et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin 2018; 68 (4): 250–281. doi: 10.3322/caac.21457.
8. O‘Sullivan DE, Sutherland RL, Town S et al. Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2022; 20 (6): 1229–1240. doi: 10.1016/j.cgh.2021.01.037.
9. Syed AR, Thakkar P, Horne ZD et al. Old vs new: Risk factors predicting early onset colorectal cancer. World J Gastrointest Oncol 2019; 11 (11): 1011–1020. doi: 10.4251/wjgo.v11.i11. 1011.
10. Gausman V, Dornblaser D, Anand S et al. Risk Factors Associated With Early-Onset Colorectal Cancer. Clin Gastroenterol Hepatol 2020; 18 (12): 2752–2759 e2752. doi: 10.1016/j.cgh.2019.10.009.
11. Venugopal A, Stoffel EM. Colorectal Cancer in Young Adults. Curr Treat Options Gastroenterol 2019; 17 (1): 89–98. doi: 10.1007/s119 38-019-00219-4.
12. Saluja SS, Manipadam JM, Mishra PK et al. Young onset colorectal cancer: How does it differ from its older counterpart? Indian J Cancer 2014; 51 (4): 565–569. doi: 10.4103/0019-509X.175350.
13. Kneuertz PJ, Chang GJ, Hu CY et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg 2015; 150 (5): 402–409. doi: 10.1001/jamasurg.2014.3572.
14. Indini A, Bisogno G, Cecchetto G et al. Gastrointestinal tract carcinoma in pediatric and adolescent age: The Italian TREP project experience. Pediatr Blood Cancer 2017; 64 (12). doi: 10.1002/pbc.26658.
15. Cercek A, Chatila WK, Yaeger R et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J Natl Cancer Inst 2021; 113 (12): 1683–1692. doi: 10.1093/ jnci/djab124.
16. O‘Connell JB, Maggard MA, Liu JH et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003; 69 (10): 866–872.
17. Falt P, Urban O, Suchanek S et al. Doporučené postupy České gastroenterologické společnosti ČLS JEP pro diagnostickou a terapeutickou koloskopii. Gastroent Hepatol 2016; 70 (6): 523–538. doi: 10.14735/amgh2016csgh. info19.
18. Pearlman R, Frankel WL, Swanson B et al. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. JAMA Oncol 2017; 3 (4): 464–471. doi: 10.1001/jamaoncol. 2016.5194.
19. Stoffel EM, Koeppe E, Everett J et al. Germline Genetic Features of Young Individuals With Colorectal Cancer. Gastroenterology 2018; 154 (4): 897.e1–905.e1. doi: 10.1053/j.gastro.2017.11. 004.
20. O‘Keefe SJ: Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 2016, 13 (12): 691–706. doi: 10.1038/nrgastro.2016.165.
21. Hofseth LJ, Hebert JR, Chanda A et al. Early-onset colorectal cancer: initial clues and current views. Nat Rev Gastroenterol Hepatol 2020; 17 (6): 352–364. doi: 10.1038/s41575-019-02 53-4.
Štítky
Paediatric gastroenterology Gastroenterology and hepatology SurgeryČlánok vyšiel v časopise
Gastroenterology and Hepatology
2023 Číslo 3
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- Bowel preparation before colonoscopy – comparison of bowel cleansing quality and patient’s tolerance of several bowel cleansing devices
- Endoscopic submucosal dissection in the rectum – our experience
- Bleeding from duodenal varices as an unusual complication of portal hypertension
- The role of fluorescence in situ hybridization in primary diagnosis of distal biliary strictures